Journal for ImmunoTherapy of Cancer Citation Rate 2026

ISSN 2051-1426 BMJ GB

Q1 Quartile Open Access Top Tier

About Journal for ImmunoTherapy of Cancer

Journal for ImmunoTherapy of Cancer (JIC) is a peer-reviewed academic journal, published by BMJ in GB. It is catalogued under ISSN 2051-1426.

Journal for ImmunoTherapy of Cancer Citation Rate 2026 — In Context

Journal for ImmunoTherapy of Cancer has a 2025 2-Year Citation Rate (OpenAlex) of 7.57, placing it in the Q1 quartile. This is the average number of citations the journal's recent articles received over a two-year window, computed from OpenAlex open citation data — not a OpenAlex Journal Impact Factor.

As a fully open-access publication, Journal for ImmunoTherapy of Cancer makes all articles freely available to readers for an Article Processing Charge of approximately $2600 USD.

Researchers looking to publish in Journal for ImmunoTherapy of Cancer should review the journal's submission tips and verify the latest indexing status against Scopus, DOAJ, and Web of Science using our indexing tracker. To compare Journal for ImmunoTherapy of Cancer against similar journals in the field, use our journal comparison tool.

Submission Tips for Journal for ImmunoTherapy of Cancer
  • Budget $2600 for the Article Processing Charge. Check if your institution or funder covers OA fees.
ISSN (Print) 2051-1426
Publisher BMJ
Country United Kingdom
APC / Cost $2600 USD
In-depth profile & metrics

Journal for ImmunoTherapy of Cancer is published by BMJ and based in United Kingdom. It publishes open access with an article-processing charge of USD 2600.

Journal for ImmunoTherapy of Cancer is indexed in OpenAlex. OpenAlex tracking provides an open, citable record of its output even where commercial indexing is absent.

Its most recent citation rate stands at 7.573.

Links
Frequently Asked Questions about Journal for ImmunoTherapy of Cancer

The current impact factor of Journal for ImmunoTherapy of Cancer is 7.573.

Yes, Journal for ImmunoTherapy of Cancer is an open access journal.

The Article Processing Charge (APC) for Journal for ImmunoTherapy of Cancer is $2600 USD.

Journal for ImmunoTherapy of Cancer is published by BMJ.

Journal for ImmunoTherapy of Cancer shows strong legitimacy signals: it is indexed in DOAJ, OpenAlex. Indexing in recognised databases such as Scopus and DOAJ is a reliable indicator of a peer-reviewed, non-predatory journal, because predatory titles are typically excluded from them. Always confirm the journal's scope and editorial board fit your work before submitting.

The ISSN of Journal for ImmunoTherapy of Cancer is 2051-1426.

Journal for ImmunoTherapy of Cancer sits in the Q1 quartile based on its latest impact factor of 7.57, ranked across all journals in our database.
Live Indexing Status
Updated April 2026

Track real-time indexing metrics to ensure this journal meets your academic requirements.

OpenAlex
Verified
DOAJ
Indexed OA
Predatory Check
Clean
Citation Rate
7.573
2-Year Citation Rate (OpenAlex) · 2025
Historical Trend
Initial data points only
Citation Rate by Year
Year Value Source
2025 7.573 2-Year Mean Citedness (OpenAlex)

Metrics are sourced from OpenAlex, DOAJ and Scopus and reflect the latest data we hold. The headline figure is a 2-year citation rate (OpenAlex), not a Clarivate Impact Factor. Always verify against the journal's official site before relying on it. See our Methodology or report a correction.

Metadata

Last updated: Apr 24, 2026

Updated by: openalex_bulk

OpenAlex ID: S2754803477

Get weekly updates

Free. Monday morning. New citation rates, CFPs, indexing alerts, predatory watch list. One-click unsubscribe.

Comparison Shortlist
0 journals
Est. APC Budget: $0
Compare Now
Compare 0 Open → Clear
Save your viewing history
You've browsed several journals this session. Sign in to track them in one place and get weekly impact-factor updates.
Save with Google